The present invention relates to therapeutic FVIII antibodies. In particular, the present invention relates to FVIII antibodies having the ability to prolong the circulatory half life of FVIII. The present invention furthermore relates to use of such antibodies in treatment and prophylaxis of haemophilia A.
申请公布号
WO2012038315(A1)
申请公布日期
2012.03.29
申请号
WO2011EP65986
申请日期
2011.09.15
申请人
NOVO NORDISK A/S;OESTERGAARD, HENRIK;HILDEN, IDA;HOLMBERG, HEIDI LINDGREEN;LAMBERTH, KASPER;CLAUSEN, JES THORN
